Cheng Chen Selected Research

Cheng Chen Research Topics

Disease

189	Neoplasms (Cancer) 10/2022 - 02/2006
47	Infections 05/2022 - 02/2007
45	Inflammation (Inflammations) 10/2022 - 11/2012
33	Neoplasm Metastasis (Metastasis) 10/2022 - 05/2012
29	Carcinogenesis 05/2022 - 01/2013
21	Lung Neoplasms (Lung Cancer) 05/2022 - 01/2009
21	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 06/2012
20	Fibrosis (Cirrhosis) 10/2022 - 01/2013
20	Osteoarthritis 04/2022 - 12/2010
18	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2012
17	Pain (Aches) 05/2022 - 03/2011
17	Stroke (Strokes) 12/2021 - 07/2007
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 03/2015
15	Diabetic Nephropathies (Diabetic Nephropathy) 05/2022 - 05/2013
15	Hypoxia (Hypoxemia) 01/2022 - 10/2006
15	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 05/2012
14	Stomach Neoplasms (Stomach Cancer) 10/2022 - 07/2013
14	Obesity 07/2022 - 02/2011
14	Carcinoma (Carcinomatosis) 01/2022 - 07/2011
12	Liver Neoplasms (Liver Cancer) 11/2021 - 06/2012
11	COVID-19 05/2022 - 01/2020
11	Hypertension (High Blood Pressure) 04/2022 - 05/2010
11	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2011
11	Wounds and Injuries (Trauma) 01/2022 - 01/2012
10	Tuberculosis (Tuberculoses) 05/2022 - 01/2013
10	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 07/2007
9	Adenocarcinoma of Lung 10/2022 - 01/2016
9	Body Weight (Weight, Body) 05/2022 - 02/2011
9	Non-alcoholic Fatty Liver Disease 04/2022 - 04/2017
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2014
9	Pneumonia (Pneumonitis) 07/2021 - 07/2016
8	Atrial Fibrillation 04/2022 - 01/2018
8	Glioma (Gliomas) 01/2022 - 01/2017
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 08/2013
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2021 - 06/2011
7	Dementia (Dementias) 11/2022 - 01/2018
7	Hypertrophy 08/2022 - 03/2014
7	Disease Progression 05/2022 - 11/2016
7	Chronic Renal Insufficiency 02/2022 - 08/2015
7	Insulin Resistance 01/2022 - 01/2018
7	Melanoma (Melanoma, Malignant) 01/2022 - 01/2017
7	Nasopharyngeal Carcinoma 12/2021 - 01/2012
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2021 - 01/2017
7	Ischemia 01/2021 - 10/2006
6	Diabetes Mellitus 05/2022 - 09/2012
6	Brain Ischemia (Cerebral Ischemia) 02/2022 - 04/2015
6	Myocardial Infarction 01/2022 - 01/2018
6	Ischemic Stroke 01/2022 - 01/2018
6	Hyperglycemia 01/2022 - 10/2006
6	Heart Failure 01/2022 - 07/2015
6	Hypercholesterolemia 12/2021 - 03/2015
6	Pituitary Neoplasms (Pituitary Adenoma) 07/2021 - 11/2017
6	Necrosis 06/2021 - 02/2006
6	Asthma (Bronchial Asthma) 03/2021 - 08/2010
6	Human Influenza (Influenza) 01/2021 - 10/2017

Drug/Important Bio-Agent (IBA)

76	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2005
45	Pharmaceutical PreparationsIBA 01/2022 - 02/2007
38	Biomarkers (Surrogate Marker)IBA 04/2022 - 06/2012
34	Biological ProductsIBA 10/2022 - 04/2006
27	CytokinesIBA 07/2022 - 05/2012
26	Phosphotransferases (Kinase)IBA 01/2022 - 03/2013
26	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2006
25	Long Noncoding RNAIBA 01/2022 - 01/2016
24	Messenger RNA (mRNA)IBA 05/2022 - 10/2006
21	MicroRNAs (MicroRNA)IBA 05/2022 - 12/2012
17	RNA (Ribonucleic Acid)IBA 05/2022 - 12/2018
13	LipidsIBA 01/2022 - 01/2014
12	Interleukin-6 (Interleukin 6)IBA 10/2022 - 01/2017
12	VaccinesIBA 01/2022 - 12/2014
11	Opioid Analgesics (Opioids)IBA 11/2022 - 10/2018
11	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 07/2012
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2021 - 06/2011
10	Therapeutic UsesIBA 01/2022 - 03/2007
10	CollagenIBA 01/2022 - 06/2011
10	CholesterolIBA 12/2021 - 02/2011
10	Transcription Factors (Transcription Factor)IBA 06/2021 - 04/2012
9	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2015
9	Indicators and Reagents (Reagents)IBA 12/2021 - 08/2015
8	Circular RNAIBA 10/2022 - 10/2018
8	Sirtuin 1IBA 07/2022 - 12/2013
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022 - 02/2006
8	CateninsIBA 02/2022 - 01/2014
8	Insulin (Novolin)FDA Link 01/2022 - 01/2007
8	salicylhydroxamic acid (SHAM)IBA 03/2021 - 10/2006
8	Advanced Glycation End ProductsIBA 01/2019 - 12/2010
7	CadmiumIBA 05/2022 - 11/2015
7	Peptides (Polypeptides)IBA 01/2022 - 06/2012
7	EnzymesIBA 09/2021 - 02/2007
7	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 12/2013
6	Oxygen (Dioxygen)IBA 05/2022 - 04/2012
6	AntioxidantsIBA 01/2022 - 04/2016
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 07/2016
6	Antiviral Agents (Antivirals)IBA 12/2021 - 03/2016
6	Amino Acids FDA Link 01/2020 - 01/2018
6	ErbB Receptors (EGF Receptor)IBA 01/2020 - 07/2011

Therapy/Procedure

87	Therapeutics 10/2022 - 03/2007
33	Drug Therapy (Chemotherapy) 01/2022 - 06/2011
17	Radiotherapy 06/2022 - 07/2012
14	Immunotherapy 05/2022 - 08/2009
6	Length of Stay 05/2022 - 04/2014